Matches in SemOpenAlex for { <https://semopenalex.org/work/W4328049234> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W4328049234 endingPage "961" @default.
- W4328049234 startingPage "955" @default.
- W4328049234 abstract "Abstract Background Eyelid ptosis following periocular onabotulinumtoxinA (BoNT-A) treatment is a known complication that can be frustrating for both patients and practitioners. Iatrogenic blepharoptosis occurs due to local spread of the BoNT-A from the periocular region into the levator palpebrae superioris muscle. Although injectors should have a thorough understanding of the relevant anatomy in order to prevent it, BoNT-A induced ptosis can occur even in the most experienced hands. Objectives The aim of this study was to describe a case series of patients treated effectively with topical oxymetazoline HCl 0.1% and pretarsal BoNT-A injections in the setting of botox-induced ptosis. Methods The study group consisted of 8 patients who had undergone recent cosmetic BoNT-A treatment preceding the sudden onset of unilateral upper eyelid ptosis. Results A diagnosis of severe ptosis (>3 mm) was made in all the cases in this series. Pretarsal BoNT-A injections alone or in association with topical administration of Upneeq eyedrops (Upneeq, Osmotica Pharmaceuticals, Marietta, GA) significantly reversed the ptosis in all treated cases. Conclusions This is the first documented case series of patients treated effectively with topical oxymetazoline HCl 0.1% and pretarsal BoNT-A injections in the setting of botox-induced ptosis. This treatment combination is a safe and effective option in these cases. Level of Evidence: 4" @default.
- W4328049234 created "2023-03-22" @default.
- W4328049234 creator A5000606268 @default.
- W4328049234 creator A5026691146 @default.
- W4328049234 creator A5031063691 @default.
- W4328049234 creator A5033574542 @default.
- W4328049234 creator A5071207795 @default.
- W4328049234 creator A5073294639 @default.
- W4328049234 creator A5081176762 @default.
- W4328049234 creator A5084961748 @default.
- W4328049234 date "2023-03-21" @default.
- W4328049234 modified "2023-10-17" @default.
- W4328049234 title "Management of Severe Botulinum-Induced Eyelid Ptosis With Pretarsal Botulinum Toxin and Oxymetazoline Hydrochloride 0.1%" @default.
- W4328049234 cites W1978910356 @default.
- W4328049234 cites W2180840415 @default.
- W4328049234 cites W3081660932 @default.
- W4328049234 cites W3090460407 @default.
- W4328049234 cites W3191638370 @default.
- W4328049234 cites W4200449265 @default.
- W4328049234 doi "https://doi.org/10.1093/asj/sjad070" @default.
- W4328049234 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36943792" @default.
- W4328049234 hasPublicationYear "2023" @default.
- W4328049234 type Work @default.
- W4328049234 citedByCount "1" @default.
- W4328049234 countsByYear W43280492342023 @default.
- W4328049234 crossrefType "journal-article" @default.
- W4328049234 hasAuthorship W4328049234A5000606268 @default.
- W4328049234 hasAuthorship W4328049234A5026691146 @default.
- W4328049234 hasAuthorship W4328049234A5031063691 @default.
- W4328049234 hasAuthorship W4328049234A5033574542 @default.
- W4328049234 hasAuthorship W4328049234A5071207795 @default.
- W4328049234 hasAuthorship W4328049234A5073294639 @default.
- W4328049234 hasAuthorship W4328049234A5081176762 @default.
- W4328049234 hasAuthorship W4328049234A5084961748 @default.
- W4328049234 hasConcept C126322002 @default.
- W4328049234 hasConcept C141071460 @default.
- W4328049234 hasConcept C170493617 @default.
- W4328049234 hasConcept C2777478456 @default.
- W4328049234 hasConcept C2778938600 @default.
- W4328049234 hasConcept C2780042274 @default.
- W4328049234 hasConcept C2780446394 @default.
- W4328049234 hasConcept C2781194658 @default.
- W4328049234 hasConcept C2781302119 @default.
- W4328049234 hasConcept C42219234 @default.
- W4328049234 hasConcept C71924100 @default.
- W4328049234 hasConcept C81182388 @default.
- W4328049234 hasConceptScore W4328049234C126322002 @default.
- W4328049234 hasConceptScore W4328049234C141071460 @default.
- W4328049234 hasConceptScore W4328049234C170493617 @default.
- W4328049234 hasConceptScore W4328049234C2777478456 @default.
- W4328049234 hasConceptScore W4328049234C2778938600 @default.
- W4328049234 hasConceptScore W4328049234C2780042274 @default.
- W4328049234 hasConceptScore W4328049234C2780446394 @default.
- W4328049234 hasConceptScore W4328049234C2781194658 @default.
- W4328049234 hasConceptScore W4328049234C2781302119 @default.
- W4328049234 hasConceptScore W4328049234C42219234 @default.
- W4328049234 hasConceptScore W4328049234C71924100 @default.
- W4328049234 hasConceptScore W4328049234C81182388 @default.
- W4328049234 hasIssue "9" @default.
- W4328049234 hasLocation W43280492341 @default.
- W4328049234 hasLocation W43280492342 @default.
- W4328049234 hasOpenAccess W4328049234 @default.
- W4328049234 hasPrimaryLocation W43280492341 @default.
- W4328049234 hasRelatedWork W2060000726 @default.
- W4328049234 hasRelatedWork W2330216616 @default.
- W4328049234 hasRelatedWork W2412979782 @default.
- W4328049234 hasRelatedWork W3014892843 @default.
- W4328049234 hasRelatedWork W3048735824 @default.
- W4328049234 hasRelatedWork W3181292649 @default.
- W4328049234 hasRelatedWork W4240849183 @default.
- W4328049234 hasRelatedWork W4255361758 @default.
- W4328049234 hasRelatedWork W4366725249 @default.
- W4328049234 hasRelatedWork W4387364562 @default.
- W4328049234 hasVolume "43" @default.
- W4328049234 isParatext "false" @default.
- W4328049234 isRetracted "false" @default.
- W4328049234 workType "article" @default.